Literature DB >> 6438654

The pharmacology and clinical uses of tamoxifen.

B J Furr, V C Jordan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6438654     DOI: 10.1016/0163-7258(84)90043-3

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  136 in total

1.  The Role of Chemoendocrine Agents in Postoperative Adjuvant Therapy for Breast Cancer: Meta-analysis of the First Collaborative Studies of Postoperative Adjuvant Chemoendocrine Therapy for Breast Cancer (ACETBC).

Authors: 
Journal:  Breast Cancer       Date:  1994-07-30       Impact factor: 4.239

2.  Serum elimination half-life of tamoxifen and its metabolites in patients with advanced breast cancer.

Authors:  D de Vos; P H Slee; D Stevenson; R J Briggs
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 3.  Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.

Authors:  P E Lønning; E A Lien; S Lundgren; S Kvinnsland
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

Review 4.  Conditional gene expression in the mouse inner ear using Cre-loxP.

Authors:  Brandon C Cox; Zhiyong Liu; Marcia M Mellado Lagarde; Jian Zuo
Journal:  J Assoc Res Otolaryngol       Date:  2012-04-24

Review 5.  Uridine 5'-diphospho-glucuronosyltransferase genetic polymorphisms and response to cancer chemotherapy.

Authors:  Jacqueline Ramírez; Mark J Ratain; Federico Innocenti
Journal:  Future Oncol       Date:  2010-04       Impact factor: 3.404

6.  The effect of adjuvant therapy with or without tamoxifen on the endocrine function of patients with breast cancer.

Authors:  T Yasumura; T Akami; M Mitsuo; T Oka; K Naitoh; T Yamamoto; H Honjyo; H Okada
Journal:  Jpn J Surg       Date:  1990-07

7.  Estrogen receptor, calcium mobilization and rat sperm motility.

Authors:  G Sethi Saberwal; M K Sharma; N Balasinor; J Choudhary; H S Juneja
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

Review 8.  Pharmacokinetics of selective estrogen receptor modulators.

Authors:  Karla C Morello; Gregory T Wurz; Michael W DeGregorio
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

9.  Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen.

Authors:  N I Ntukidem; A T Nguyen; V Stearns; M Rehman; A Schott; T Skaar; Y Jin; P Blanche; L Li; S Lemler; J Hayden; R M Krauss; Z Desta; D A Flockhart; D F Hayes
Journal:  Clin Pharmacol Ther       Date:  2007-08-22       Impact factor: 6.875

10.  Pathology of endometrium treated with tamoxifen.

Authors:  S M Ismail
Journal:  J Clin Pathol       Date:  1994-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.